Mind Medicine (MindMed) (MNMD) Competitors $5.60 +0.05 (+0.90%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$5.62 +0.03 (+0.45%) As of 09:23 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestTrendsBuy This Stock MNMD vs. GLPG, CNTA, BEAM, AGIO, KNSA, ANIP, JANX, APGE, KYMR, and ARWRShould you be buying Mind Medicine (MindMed) stock or one of its competitors? The main competitors of Mind Medicine (MindMed) include Galapagos (GLPG), Centessa Pharmaceuticals (CNTA), Beam Therapeutics (BEAM), Agios Pharmaceuticals (AGIO), Kiniksa Pharmaceuticals (KNSA), ANI Pharmaceuticals (ANIP), Janux Therapeutics (JANX), Apogee Therapeutics (APGE), Kymera Therapeutics (KYMR), and Arrowhead Pharmaceuticals (ARWR). These companies are all part of the "pharmaceutical products" industry. Mind Medicine (MindMed) vs. Galapagos Centessa Pharmaceuticals Beam Therapeutics Agios Pharmaceuticals Kiniksa Pharmaceuticals ANI Pharmaceuticals Janux Therapeutics Apogee Therapeutics Kymera Therapeutics Arrowhead Pharmaceuticals Mind Medicine (MindMed) (NASDAQ:MNMD) and Galapagos (NASDAQ:GLPG) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, analyst recommendations, risk, valuation, institutional ownership, community ranking, earnings and media sentiment. Is MNMD or GLPG more profitable? Galapagos' return on equity of 0.00% beat Mind Medicine (MindMed)'s return on equity.Company Net Margins Return on Equity Return on Assets Mind Medicine (MindMed)N/A -47.56% -35.55% Galapagos N/A N/A N/A Which has more risk and volatility, MNMD or GLPG? Mind Medicine (MindMed) has a beta of 2.54, meaning that its stock price is 154% more volatile than the S&P 500. Comparatively, Galapagos has a beta of 0.16, meaning that its stock price is 84% less volatile than the S&P 500. Does the media refer more to MNMD or GLPG? In the previous week, Galapagos had 6 more articles in the media than Mind Medicine (MindMed). MarketBeat recorded 8 mentions for Galapagos and 2 mentions for Mind Medicine (MindMed). Galapagos' average media sentiment score of 0.58 beat Mind Medicine (MindMed)'s score of 0.14 indicating that Galapagos is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mind Medicine (MindMed) 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Galapagos 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders have more ownership in MNMD or GLPG? 27.9% of Mind Medicine (MindMed) shares are owned by institutional investors. Comparatively, 32.5% of Galapagos shares are owned by institutional investors. 2.3% of Mind Medicine (MindMed) shares are owned by insiders. Comparatively, 2.9% of Galapagos shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community prefer MNMD or GLPG? Galapagos received 411 more outperform votes than Mind Medicine (MindMed) when rated by MarketBeat users. However, 93.22% of users gave Mind Medicine (MindMed) an outperform vote while only 63.84% of users gave Galapagos an outperform vote. CompanyUnderperformOutperformMind Medicine (MindMed)Outperform Votes5593.22% Underperform Votes46.78%GalapagosOutperform Votes46663.84% Underperform Votes26436.16% Which has higher earnings and valuation, MNMD or GLPG? Galapagos has higher revenue and earnings than Mind Medicine (MindMed). CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMind Medicine (MindMed)N/AN/A-$95.73M-$2.08-2.69Galapagos$275.65M5.71$80.16MN/AN/A Do analysts recommend MNMD or GLPG? Mind Medicine (MindMed) presently has a consensus price target of $25.11, indicating a potential upside of 348.41%. Galapagos has a consensus price target of $25.33, indicating a potential upside of 6.09%. Given Mind Medicine (MindMed)'s stronger consensus rating and higher probable upside, analysts clearly believe Mind Medicine (MindMed) is more favorable than Galapagos.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mind Medicine (MindMed) 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 3 Strong Buy rating(s) 3.23Galapagos 4 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 SummaryGalapagos beats Mind Medicine (MindMed) on 9 of the 15 factors compared between the two stocks. Remove Ads Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MNMD vs. The Competition Export to ExcelMetricMind Medicine (MindMed)Medicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$422.06M$1.17B$5.33B$7.57BDividend YieldN/AN/A5.11%4.32%P/E Ratio-2.489.6921.7317.82Price / SalesN/A7.42379.2094.61Price / CashN/A10.4038.1534.64Price / Book2.951.186.464.00Net Income-$95.73M-$56.07M$3.20B$247.23M7 Day Performance-1.41%2.62%2.86%1.45%1 Month Performance-11.81%-10.00%-8.55%-6.24%1 Year Performance-43.32%-42.94%10.47%0.60% Mind Medicine (MindMed) Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MNMDMind Medicine (MindMed)1.8746 of 5 stars$5.60+0.9%$25.11+348.4%-42.7%$422.06MN/A-2.4840Analyst RevisionNews CoverageGLPGGalapagos0.6479 of 5 stars$23.07-2.9%$25.33+9.8%-19.9%$1.52B$275.65M0.001,123Upcoming EarningsNews CoverageHigh Trading VolumeCNTACentessa Pharmaceuticals2.9155 of 5 stars$11.34-2.9%$27.71+144.4%+10.8%$1.52B$6.85M-7.46200Gap DownHigh Trading VolumeBEAMBeam Therapeutics2.9534 of 5 stars$15.18-0.6%$49.45+225.8%-32.8%$1.52B$63.52M-8.64510Short Interest ↑High Trading VolumeAGIOAgios Pharmaceuticals3.8689 of 5 stars$26.00+0.9%$56.57+117.6%-4.9%$1.49B$36.50M2.29390Analyst RevisionNews CoverageKNSAKiniksa Pharmaceuticals2.6176 of 5 stars$20.18-0.9%$37.17+84.2%+21.7%$1.47B$423.24M-144.68220Upcoming EarningsNews CoveragePositive NewsGap UpANIPANI Pharmaceuticals3.6146 of 5 stars$66.95-0.9%$79.75+19.1%+4.9%$1.47B$614.38M-122.64600JANXJanux Therapeutics2.6977 of 5 stars$24.53-4.8%$92.44+276.8%-44.0%$1.47B$10.59M-21.2030Positive NewsAPGEApogee Therapeutics2.0489 of 5 stars$32.01-1.0%$92.17+188.0%-38.1%$1.43BN/A-13.1591News CoverageKYMRKymera Therapeutics1.4178 of 5 stars$21.84-1.0%$56.36+158.0%-26.0%$1.43B$47.07M-9.38170News CoveragePositive NewsGap DownARWRArrowhead Pharmaceuticals3.407 of 5 stars$10.20-4.5%$41.44+306.3%-46.4%$1.40B$2.50M-1.98400News Coverage Remove Ads Related Companies and Tools Related Companies GLPG Alternatives CNTA Alternatives BEAM Alternatives AGIO Alternatives KNSA Alternatives ANIP Alternatives JANX Alternatives APGE Alternatives KYMR Alternatives ARWR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MNMD) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMusk's panic move: What the world's richest man fears is comingWhether you have modest savings of $10,000 or substantial wealth of $10 million, this information could determ...InvestorPlace | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mind Medicine (MindMed) Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mind Medicine (MindMed) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MNMD Stock Free MNMD Stock Alerts